University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 23 of 35
Study of Hyperkyphosis, Exercise and Function-SHEAF
NCT01751685
Specialized Centers of Research (SCOR)on Sex Differences - Kyphosis Study
NCT01766674
Community Choirs To Promote Healthy Aging; Community of Voices Chorus
NCT01869179
A Controlled Trial of Topiramate Treatment for Alcohol Dependence in Veterans With PTSD
NCT01749215
Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging
NCT01717937
Focal Ablation of Cervical Precancer
NCT01709773
Pilot Study of the Effects of Exercise on Aging Among Older Persons With HIV
NCT01860261
Optimal Location of Local Anesthetic Injection for Ultrasound Guided Interscalene Block
NCT01877330
Improving Advance Care Planning by Preparing Diverse Seniors for Decision Making
NCT01990235
Effects of Gastric pH on the Pharmacokinetics of Atazanavir
NCT01759875
RCT of an Integrative Intervention for Non-Treatment-Seeking Meth Users
NCT01926184
Preoperative and Intraoperative Factors Related to the Development of Ptosis After Retinal Surgery
NCT01752478
PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
NCT01734512
Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time
NCT01877941
Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes
NCT01691079
The Influence of a Bupivacaine Digital Nerve Block Using Rev G.
NCT01750554
Yoga for Chronic Low Back Pain and Its Mechanism of Action (YoMA)
NCT01739140
A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS)
NCT01821443
Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI
NCT01750268
Severe Asthma Research Program (SARP)- San Francisco Clinical Site
NCT01718197
Infrared Pupillometry During General Anesthesia to Predict Pain
NCT02058511
Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
NCT01687673
The MOTHER (Mobile Technologies to Help Enhancing Regular Physical Activity) Trial for Pregnant Women
NCT01461707
Anakinra as a Treatment for Hydradenitis Suppurativa
NCT01516749
Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial (CAF-PINT)
NCT01892969
Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome
NCT01736956
Biomarker Discovery for Novel Drug Development in Idiopathic Pulmonary Fibrosis
NCT01718990
A Pilot Study of the Effects of Diet and Behavioral Interventions on Health in Diabetics
NCT01713764
Meditation for Depression
NCT01671436
Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients
NCT01624948
Adult Study Oxytocin - fMRI
NCT02566356
Optimizing Vitamin D in the Elderly
NCT01554241
Countering Young Adult Tobacco Marketing in Bars
NCT01686178
Study of the Collaborative Life Skills Program
NCT01686724
The HOLIDAY (HOw ALcohol InDuces Atrial TachYarrhythmias) Study
NCT01996943
Lessening Incontinence by Learning Yoga
NCT01672190
Hyperglycemia in Renal Transplantation
NCT01643382
Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors
NCT01670175
Study of Mitomycin-C Application in Laryngotracheal Stenosis
NCT01523275
CF And Effects of Drugs Mixed Ex Vivo With Sputum for Mucolytic Treatment
NCT01533636
Computer-Facilitated 5A's for Smoking Cessation in Primary Care
NCT02046408
Mechanisms of the Nicotine Metabolism Effect on Tobacco Dependence
NCT01627392
Prehospital Cervical Ripening Before Induction and the Maternal Experience
NCT01641601
BKM120 Combined With Vemurafenib (PLX4032) in BRAFV600E/K Mutant Advanced Melanoma
NCT01512251
San Francisco Stop Smoking App - Pilot Study
NCT01626326
Comparison of Internet Stop Smoking Intervention to Usual Care on Smoking Cessation at 6 Months
NCT01639079
Use of Abbott RealTime CT/NG to Detect Chlamydia Trachomatis [CT] & Neisseria Gonorrhoeae [NG] in Men Who Have Sex With Men [MSM]
NCT01291264
Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
NCT01596699
The Effect of Therapeutic Hypothermia on Deceased Donor Renal Graft Outcomes - a Randomized Controlled Trial From the Region 5 Donor Management Goals Workgroup
NCT01680744
Comparative Accuracy of Three Versions of Non-Invasive Hemoglobin Monitoring
NCT01604668
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.